Understanding views of patients on biologics for psoriasis amid the COVID-19 pandemic.

Pandher, K; Porter, C L; Patel, H S; Huang, W W; Feldman, S R

Pandher, K; Porter, C L; Patel, H S; Huang, W W; Feldman, S R.

Afiliação

Pandher K; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Porter CL; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Patel HS; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Huang WW; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Feldman SR; Center for Dermatology Research, Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, NC, USA.

J Eur Acad Dermatol Venereol ; 35(4): e249-e251, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33332687

Assuntos

Produtos Biológicos/uso terapêutico; COVID-19/epidemiologia; Conhecimentos, Atitudes e Prática em Saúde; Psoríase/tratamento farmacológico; COVID-19/diagnóstico; COVID-19/terapia; Humanos; Psoríase/psicologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos / Conhecimentos, Atitudes e Prática em Saúde / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google